Evidence-based urology in practice: when to believe a subgroup analysis?

BJU Int. 2010 Jan;105(2):162-4. doi: 10.1111/j.1464-410X.2009.09053.x. Epub 2009 Nov 12.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Benzenesulfonates / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Evidence-Based Medicine*
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Male
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib